Physician profile
Barton P Smith
NPI 1205801040
$594.98
in general payments reported to CMS, 2019-2025
14 companies · $22.53 in 2025
The $22.53 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $16.78 · 2021: $45.41 · 2022: $194 · 2023: $22.09 · 2024: $194 · 2025: $22.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $95.41 | 2024 | Ovitex 2s |
| Davol INC. | $83.73 | 2019-2025 | Phasix Mesh |
| Baxter Healthcare | $76.47 | 2022 | |
| Merck Sharp & Dohme LLC | $70.79 | 2024 | Keytruda |
| Ethicon US, LLC | $64.13 | 2021-2022 | |
| Integra Lifesciences Corporation | $47.20 | 2022-2023 | Durasorb Monofilament Mesh |
| Tactile Systems Technology INC | $29.40 | 2019 | |
| Innocoll Pharmaceuticals Limited | $20.99 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.02 | 2022 | |
| Kci USA, INC. | $19.73 | 2019 | |
| Teleflex LLC | $17.58 | 2019 | |
| Myriad Genetic Laboratories, INC. | $16.82 | 2022 | |
| Braintree Laboratories, INC. | $16.78 | 2020 | |
| Lemaitre Vascular, INC. | $15.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barton Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.